跳至主要内容
临床试验/CTRI/2025/03/081710
CTRI/2025/03/081710尚未招募3 期

An Open Label Single Arm Clinical Study to Evaluate the Efficacy of Ayurvedic Comprehensive Management of Stage 4 Cancer Vis-a-Vis Arbuda

Dr Spoorthi S N1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年3月20日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To evaluate the efficacy of Ayurvedic comprehensive Management of Stage 4 Cancer

研究概览

简要总结

•Neoplasmor tumour is “ A mass of tissue formed as a result of abnormal, excessive,uncoordinated, autonomous and purposeless proliferation of cells, even afterremoval of growth stimulus which caused it”.

•Canceris a second leading cause of death globally. In India one in nine people arelikely to develop cancer in his/her lifetime. Recently India is been named theCancer capital of the world

•Dependingupon the stage of cancer, treatment modalities used are surgery, chemotherapyand radiotherapy, hormonal treatment and Immunotherapy.

•Accessibility,affordability, compromised quality of life and variable success rates are theproblem areas of conventional cancer care.

•Inclassics, Cancer can be corelated with Arbudaand is defined as a swelling occurring in any part of the body. Due tovitiation of Tridosha,afflicting MamsaDhatu,which is circular, fixed, slightly painful, big or widespread, deep seated,slowly growing and non suppurative.

•Nityanandarasa, Gandeera rasayana, Panchatikta guggulu ghrita mentionedin Ayurvedic classics have direct indication in Arbuda, Gulma, Granti, Gandamala, Aruchi, Shwasa, Kasa.Haritakyadi yoga whichhelps in Deepana,pachana, anulomana, purana mala shodhana;These medicines can be administered in combination in the management of cancer.

•Inthis study an effort is put forth to evaluate the combined effect of Nityananda rasa, Gandeera rasayana, Guggulu thiktaka ghrita andHaritakyadi yoga inthe management of stage 4 cancer.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Subjects between the age group of 18-80 years irrespective of gender, religion and socio-economic status, type or site of stage 4 cancer.

排除标准

  • 1.Subjects who are not able to take oral medicines 2.Patients with systemic disorders which interfere with the treatment (CKD, Cardiac diseases).

结局指标

主要结局

To evaluate the efficacy of Ayurvedic comprehensive Management of Stage 4 Cancer

时间窗: 90 days

次要结局

  • To evaluate the efficacy of Ayurvedic comprehensive Management of Stage 4 Cancer(Total number of assessment-7)

研究者

发起方
Dr Spoorthi S N
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
1 期
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid TumorsColon Cancer
NCT06710847GlaxoSmithKline14
招募中
1 期
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400Pancreatic Ductal AdenocarcinomaBiliary Tract CancersEsophageal Squamous Cell CarcinomaTriple Negative Breast CancerHormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast CancerHead and Neck Squamous-Cell CarcinomaPlatinum Resistant High Grade Epithelial Ovarian CancerHepatocellular Carcinoma
NCT06084481AbbVie325
招募中
2 期
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.Epithelial Ovarian Cancer
NCT06890338AbbVie140
终止
1 期
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid TumorsSolid Tumors
NCT06158958AbbVie27
已完成
1 期
Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose PhaseSolid Malignancies
NCT02640755AstraZeneca4
Clinical Study To Evaluate the Efficacy of Ayurvedic... | 临床试验